Skip to content
Sunday, November 15, 2026
Discover expert betting tips, odds comparisons, and strateg…

Users Stopping Weight-Loss Injections Regain Weight Four Times Faster Compared to People Using Diet and Exercise

Image of medical injection and scale
Obesity treatment involves long-term strategies.

Fresh analysis reveals that people who come off popular weight-loss injections like Mounjaro or Wegovy may regain lost weight at a significantly accelerated pace than those who halt traditional diet and exercise plans.

Research printed in a prominent medical journal demonstrates that while obese people can lose a large proportion of their total mass while on the medication, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"People using such medications must be informed of the potential of rapid rebound weight gain when the treatment is stopped," cautioned lead investigator Dr. Susan Jebb.

This pace of recovery means a return to starting mass within about 18 months.

Analyzing Approaches

The study, which reviewed dozens of trials involving over 9,000 of patients, compared the outcomes of the injectable medications with older methods.

Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically experience a slower weight regain—approximately 100 grams monthly—post-intervention.

Explaining the Rapid Regain

Doctors suggest the mode of action of the drugs is key to understanding the amplified rebound.

These medications imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Artificially providing the hormone levels several times higher than normal may cause the system to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.

"Stopping of this medication means appetite is unsuppressed, making overeating far more likely."

A Lifelong Condition?

Health authorities advise the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Professionals say that, considering the significant potential of relapse, the therapy might need to be long-term.

This opinion is echoed by drug manufacturers, who state that the findings "highlight the long-term nature of excess weight," similar to managing diseases like hypertension.

Patient Experiences

Individuals who have come off the medication describe a powerful return of cravings.

"It felt as if a switch that goes on and you become extremely hungry," described an individual.

This challenge is exacerbated if individuals have not developed lasting lifestyle or habit changes during therapy.

Growing Interest

Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with demand remaining high.

  • Use is greater among women compared to men.
  • The middle-aged demographic shows the highest level of interest.
  • A large proportion obtain the drugs through private healthcare rather than the NHS.

Finally, clinicians emphasize that while the jabs are potent agents for weight loss, they are not a magic cure and lasting health benefits relies on ongoing lifestyle management.

JL
The writer

Joshua Lopez

James is an experienced sports analyst with over a decade of expertise in UK betting markets.

Brit Bets Finder

Type to search articles.